Status:
COMPLETED
A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions
Lead Sponsor:
GlaxoSmithKline
Conditions:
Healthy Subjects
Eligibility:
MALE
19-50 years
Phase:
PHASE1
Brief Summary
This proof of principle PK study will allow GSKCH to select the most favorable sustained release formulation among 3 prototypes to move to the next stage of drug development.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteer
- Body Mass Index between 19.0 - 28.0 (kg/m2) inclusive
Exclusion
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01476215
Start Date
November 1 2009
End Date
November 1 2009
Last Update
November 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MDS Pharma Services NEBRASKA
Lincoln, Nebraska, United States, 68501